← FDA Drug Approvals (Drugs@FDA)

NOURESS

NDA · New Drug Application · Sponsor: BAXTER HLTHCARE CORP · Approved 2019-12-13

Drug application

FDA Application #

NDA212535

Application type

New Drug Application

Brand name

NOURESS

Generic name

CYSTEINE HYDROCHLORIDE

Active ingredients

CYSTEINE HYDROCHLORIDE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

BAXTER HLTHCARE CORP

Manufacturer

Baxter Healthcare Corporation

First approval

2019-12-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown